Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 230.6B | 188.6B | 403.2B | 346.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | -2.5B | 6.7B | 7.3B | 7.6B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 0 | 0 | 0 | 0 |
| Pretax income | 8.4B | 5.7B | 5.5B | 5.4B |
| Tax provision | 271M | 207.9M | 175.1M | 159.7M |
| Net income | 8.1B | 5.5B | 5.3B | 5.2B |
| Basic EPS | — | 5.5 | 5.3 | 5.2 |
| Diluted EPS | — | 5.5 | 5.3 | 5.2 |
| Basic average shares | — | 1.0B | 1.0B | 1.0B |
| Diluted average shares | — | 1.0B | 1.0B | 1.0B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |